TAKAYASU ARTERITIS

Clinical trials for TAKAYASU ARTERITIS explained in plain language.

Never miss a new study

Get alerted when new TAKAYASU ARTERITIS trials appear

Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 1

Could a lung drug help heal blood vessels in rare artery disease?

Disease control Not yet recruiting

This study tests whether adding pirfenidone, a drug used for lung scarring, to standard treatment can improve blood vessel damage in people with Takayasu arteritis. About 92 adults aged 18-60 will receive either pirfenidone or a placebo for 6 months. The goal is to see if the dru…

Matched conditions: TAKAYASU ARTERITIS

Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Apr 29, 2026 08:01 UTC

TAKAYASU ARTERITIS

Get alerted when new TAKAYASU ARTERITIS trials appear

Could a lung drug help heal blood vessels in rare artery disease?